Homepage
Author:
GH Research PLC
Posted Date:
April 29, 2026
GH Research Announces Pricing of $117.5 Million Underwritten Offering
GH Research PLC
April 29, 2026
GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD
GH Research PLC
March 25, 2026
GH Research Reports Full Year 2025 Financial Results and Provides Business Update
GH Research PLC
March 5, 2026
